CFF CIO Alert: Fuel Your Pipeline
Adela Skenderasi named CIO at Cystic Fibrosis Foundation. Pitch endowment management & predictive analytics. Secure deal flow and boost commission.
Published on
Do not index
Do not index
π Battle Card: Cystic Fibrosis Foundation
Quick trigger:
Β
π€ Decision Maker in the News
- Adela Skenderasi, Chief Investment Officer Β· π [LinkedIn](https://www.linkedin.com/company/cystic-fibrosis-foundation/)
Β
π‘ Why It Matters
- Sheβll overhaul the Foundationβs endowment and venture-philanthropy model to secure sustainable funding for breakthrough CF therapies. β Source
Β
π― Core Pain Point
- Ensuring consistent, long-term funding to support high-cost research and trials
- Aligning portfolio strategy with mission-driven outcomes
Β
π° What to Pitch
- Primary: Endowment management platform β Optimize asset allocation & risk controls
- Expansion: Predictive analytics & reporting β Drive higher ROI and mission alignment
Β
πΊοΈ Quick Context
- HQ: Bethesda, MD
- Employees: β 300
- Rev: β $200 M
- Website: [cff.org](https://www.cff.org/)
Β
(Heads up: this is a Cystic Fibrosis Foundation sales triggerβdonβt let it slip!)
Β
π€Ό Competitive Intel
*Which other vendors youβll probably face to win Cystic Fibrosis Foundationβs business.*
Β
- BlackRock Aladdin β Endowment & Risk Management
- Unique edge: Institutional-grade portfolio analytics
- Evaluated by CIO for global multi-asset capabilities
- Bloomberg AIM β Asset & Investment Management
- Unique edge: Real-time market data integration
- Evaluated by Finance for trading and compliance
- FactSet β Portfolio Analytics & Research
- Unique edge: Deep multi-asset class research tools
- Evaluated by Investment Team for custom modeling
- Workday Adaptive Planning β FP&A & Forecasting
- Unique edge: Seamless budgeting with HR headcount planning
- Evaluated by CFO for financial consolidation
- Salesforce Financial Services Cloud β Foundation CRM
- Unique edge: Donor engagement & grant tracking
- Evaluated by Director of Development for fundraising sync
Β
(This is another Cystic Fibrosis Foundation sales triggerβget ahead of the pack.)
Β
β Do-Now Checklist
Connect with Adela Skenderasi on LinkedIn (link above)
Customize first-touch email highlighting investment portfolio ROI gains
Log follow-up tasks in CRM (Day 3 & Day 10)
Β
Next Step
Donβt miss out on any Cystic Fibrosis Foundation sales triggerβget intel like this daily.
Subscribe to NewsletterForLeads
Β
π§ Copy My Prompt for Personalized Cold Outreach
ββββββββββββββββββββββββββββ
βοΈ YOUR COMPANY
ββββββββββββββββββββββββββββ
OUR_COMPANY = ββ
OFFER_BRIEF = βEndowment management platform for nonprofit fundsβ
PROOF_METRIC = β15% ROI boost in 6 monthsβ
CTA_STYLE = βquick_callβ
TONE = βfriendlyβ
ββββββββββββββββββββββββββββ
π TARGET COMPANY
ββββββββββββββββββββββββββββ
NAME = Adela
COMPANY = Cystic Fibrosis Foundation
DEPT = Investment
SIZE = β TBD
BOTTLENECK = Ensuring consistent, long-term funding slows growth.
EVENT = Announces Adela Skenderasi as next Chief Investment Officer
DETAIL = Cystic Fibrosis Foundation Announces Adela Skenderasi as Next Chief Investment Officer
PAIN = Ensuring consistent, long-term funding for high-cost research
SRC = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250924109535&div=41152219
SIM_CO = Bill & Melinda Gates Foundation
WIN_METRIC = 15% higher ROI on endowment
NEXT_SIZE = β TBD
EMP_EST = β 300
REV_EST = β $200M
ββββββββββββββββββββββββ
TASK FOR CHATGPT
ββββββββββββββββββββββββ
Role: βNewsletterForLeads SDR-Assistβ.
Validate any β guesses via SRC.
EMAIL (keep breaks):
Subject: β TBD-person Investment
Adelaβnoticed your Investment team is β TBD.
Thatβs when Ensuring consistent, long-term funding slows growth.
We helped Bill & Melinda Gates Foundation fix this with Endowment management platform for nonprofit funds.
Result: 15% higher ROI on endowment.
Quick call?
PSβnext bottleneck hits β TBD.
DM β€45 words, TONE:
Saw your post about Cystic Fibrosis Foundation Announces Adela Skenderasi as Next Chief Investment Officer β Ensuring consistent, long-term funding for high-cost research.
Endowment management platform for nonprofit funds. 15% ROI boost in 6 months.
Quick chat?